Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisantrene with Fludarabine and Clofarabine in R/R AML
NCT04989335Phase 2Recruiting
- Sponsor
- Sheba Medical Center
- Start
- Aug 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bisantrene in acute myeloid leukemia (AML), sponsored by Sheba Medical Center. Started Aug 2021; status: recruiting.
02
Drugs
bisantrene
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04989335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04989335.